Related Experiment Video
Updated: Aug 12, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
p21cip1 Degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human
F Noya1, W M Chien, T R Broker
1Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA.
Abstract:
The human papillomavirus (HPV) E7 protein promotes S-phase reentry in a fraction of postmitotic, differentiated keratinocytes. Here we report that these cells contain an inherent mechanism that opposes E7-induced DNA replication. In organotypic raft cultures of primary human keratinocytes, neither cyclin E nor p21cip1 is detectable in situ. However, E7-transduced differentiated cells not in S phase accumulate abundant cyclin E and p21cip1. We show that normally p21cip1 protein is rapidly degraded by proteasomes. In the presence of E7 or E6/E7, p21cip1, cyclin E, and cyclin E2 proteins were all up-regulated. The accumulation of p21cip1 protein is a posttranscriptional event, and ectopic cyclin E expression was sufficient to trigger it. In constract, cdk2 and p27kip1 were abundant in normal differentiated cells and were not significantly affected by E7. Cyclin E, cdk2, and p21cip1 or p27kip1 formed complexes, and relatively little kinase activity was found associated with cyclin E or cdk2. In patient papillomas and E7 raft cultures, all p27kip1-positive cells were negative for bromodeoxyuridine (BrdU) incorporation, but only some also contained cyclin E and p21cip1. In contrast, all cyclin E-positive cells also contained p27kip1. When the expression of p21cip1 was reduced by rottlerin, a PKC delta inhibitor, p27kip1- and BrdU-positive cells remained unchanged. These observations show that high levels of endogenous p27kip1 can prevent E7-induced S-phase reentry. This inhibition then leads to the stabilization of cyclin E and p21cip1. Since efficient initiation of viral DNA replication requires cyclin E and cdk2, its inhibition accounts for heterogeneous viral activities in productively infected lesions.
Insights
Human papillomavirus (HPV) E7 protein drives cell cycle reentry, but keratinocytes have a defense mechanism. High p27kip1 levels block E7-induced DNA replication, stabilizing cell cycle proteins and limiting viral activity.
Area of Science:
- Cell Biology
- Virology
- Molecular Biology
Background:
- The human papillomavirus (HPV) E7 protein can induce differentiated keratinocytes to re-enter the cell cycle.
- Keratinocytes possess intrinsic mechanisms that counteract E7-driven DNA replication.
Purpose of the Study:
- To investigate the molecular mechanisms by which differentiated keratinocytes oppose HPV E7-induced S-phase reentry.
- To elucidate the roles of cell cycle regulators, specifically cyclins and cyclin-dependent kinase inhibitors (CKIs), in this process.
Main Methods:
- Organotypic raft cultures of primary human keratinocytes.
- Immunodetection of cell cycle proteins (cyclin E, p21cip1, cdk2, p27kip1) and DNA replication marker (BrdU).
- Analysis of protein stability and complex formation.
- Inhibition of p21cip1 expression using rottlerin, a PKC delta inhibitor.
Main Results:
- E7-transduced cells accumulate cyclin E and p21cip1, which are normally degraded.
- p21cip1 accumulation is post-transcriptional, triggered by ectopic cyclin E.
- High endogenous p27kip1 levels prevent E7-induced S-phase reentry, leading to cyclin E and p21cip1 stabilization.
- Inhibition of p21cip1 did not affect p27kip1 or BrdU incorporation.
Conclusions:
- Endogenous p27kip1 acts as a critical barrier to HPV E7-mediated cell cycle progression in differentiated keratinocytes.
- Stabilization of cyclin E and p21cip1 occurs due to p27kip1-mediated inhibition.
- This regulatory interplay influences the heterogeneous viral DNA replication observed in HPV-infected lesions.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
Anaphase Promoting Complex
DNA Damage Can Stall the Cell Cycle
Inhibition of CDK Activity

